Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Netsmart Adds HomeCare Accounting Solutions
Mergers and acquisitions in the Home Health & Hospice space are charging into 2018. Six deals were announced in the sector for the month of January, and more will likely turn up in the coming weeks. January’s total is already about half of the number of deals announced in this sector in the fourth quarter of 2017. It’s no surprise then that companies providing ancillary services to home health and hospice companies are seeing a surge in investor interest. Netsmart Technologies, jointly owned by Allscripts Healthcare Solutions (NYSE: MDRX) and GI Partners, has been building out front-office software solutions (think electronic health records) for providers in this area. Now... Read More »2017 Biggest Healthcare Deals by Sector
2017 was another big year for billion-dollar healthcare transactions. Among the deals that disclosed prices, 44 topped the billion-dollar mark, for a total of approximately $263.1 billion. Although that number seems high, there were 50 billion-dollar deals announced in 2015, although those totaled a slightly lower $240.1 billion. 2016 posted lower totals for both the number of billion-dollar deals (39) and combined prices ($194.1 billion). Of course the biggest healthcare deal in 2017 was the $77 billion acquisition of Aetna Inc. (NYSE: AET) by CVS Health (NYSE: CVS). But there were many more sizable transactions across the sectors, as the chart below illustrates. See how many you remember... Read More »
Hospital M&A Held Steady in Q4:17
Despite a weak third quarter, the Hospital sector’s merger and acquisition activity stayed relatively consistent, with deal volume ranging between 20 and 23 deals per quarter. The fourth quarter of 2017 posted 21 transactions, accounting for 27% of the 78 announced in the prior 12 months. Deal volume was up 40% compared with the previous quarter, but 9% lower than the same quarter in 2016. Some of the activity has been fueled by divestitures by the publicly traded companies, Community Health Systems (NYSE: CYH), Quorum Health (NYSE: QHC), and Tenet Healthcare (NYSE: THC). All are trying to lower their debt load, and for Community Health and Tenet, activist shareholders are demanding more... Read More »Health Care M&A Weekly Deals, The Week Ending January 26, 2018
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care Acquirer Target Price Pharos Capital Group, LLC Behavior Care Specialists N/A Biotechnology Acquirer Target Price Biogen Inc. KPT-350 $10 million DanDrit Biotech USA, Inc. Enochian Biopharma Inc. N/A Celgene... Read More »
Healthcare M&A Held Steady in 2017
Healthcare merger and acquisition activity held steady in the fourth quarter of 2017. Compared with the third quarter, deal volume increased 1%, to 377 transactions. Deal volume was lower than the same quarter in 2016, down 3%. Combined spending reached $114.4 billion, up 166% compared with the $43.1 billion spent in the previous quarter, according to HealthCareMandA.com. Fourth quarter deal value was 197% higher than the $38.6 billion spent in Q4:16. Health Care M&A Market – Deal Volume by Sector Q4:17 Q3:17 Q4:16 Sector Deals Deals Change Deals Change Services Behavioral Health Care 12 14 -14% 10 20% Home Health & Hospice 13 12 8% 24 -46% Hospitals 21 15 40% 23 -9%... Read More »
Deal of the Week: Aurora Cannabis/CanniMed Therapeutics
Canada’s cannabis industry is consolidating. Aurora Cannabis Inc. (OTCQX: ACBFF), the country’s second largest producer of cannabis and cannabis oil, is acquiring Saskatoon, Saskatchewan-based CanniMed Therapeutics Inc. (TSX: CMED) for approximately C$1.1 billion (US$893,343,000) in an all-stock offer. CanniMed bills itself as an international plant biopharmaceutical company with 17 years of pharmaceutical cannabis cultivation experience. The impending legalization of marijuana that is expected to become law in July 2018 is pushing marijuana producers to lock down growers who can help keep up with the expected demand. This acquisition is the largest in the global marijuana... Read More »Health Care M&A Weekly Deals, The Week Ending January 19, 2018
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price Context Therapeutics Worldwide rights to Apristor N/A eHealth Acquirer Target Price Change Healthcare National Decision Support Company N/A Elsevier Via Oncology N/A eHealth, Inc. Health, Wealth and Life... Read More »
Deal of the Week: Elsevier/Via Oncology
Deal makers took a break last week, after a long trudge through the J.P. Morgan Healthcare Conference the week before. Deal volume was light in the week of Janaury 17, 2018, but at least 70 transactions have been recorded this month. Here’s an unusual deal from the eHealth sector we picked. Elsevier, a subsidiary of RELX plc (NYSE: RELX), announced its acquisition of Via Oncology, a privately held, former subsidiary of UPMC, based in Pittsburgh. Elsevier is a global provider of information solutions for science, health and technology professionals. Via Oncology provides decision support tools for cancer. Specifically, its Via Pathways product helps cancer centers demonstrate the... Read More »
New Buyers Move in to Home Health & Hospice
The Home Health & Hospice sector is poised for big deals in 2018. As the healthcare industry shifts inexorably toward value-based reimbursement models, this sector has become the “go-to” care protocol to help drive down costs and to keep patients out of institutions. However, the pressures that existed in 2017 are still present in 2018, and even amplified now. Mark Kulik, managing director at The Braff Group, recently gave us his view of the market. Not only will the rate of M&A activity accelerate, new buyers will enter the market. “Ten years ago, people stayed in their lane. Today, we’re going out to a wider range of buyers, such as long-term care and... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
